Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2016-11-15

FDA Approved: FOLLISTIM AQ — Supplemental Application (Organon LLC)

View source ↗

Summary

The FDA approved a supplemental application for FOLLISTIM AQ (follitropin) by Organon LLC, typically updating the product’s labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Follistim AQ (follitropin)

Snippet

SUPPL AP for FOLLISTIM AQ (FOLLITROPIN)